PhageLine unpacks the science of bacteriophages, one paper at a time. From groundbreaking studies to surprising discoveries, we translate complex research into engaging conversations. Whether you are steeped in microbiology or just discovering the fascinating world of phages, PhageLine delivers a unique perspective on the science behind these bacterial predators.
PhageLine is on BlueSky (@phageline.bsky.social). Follow us never to miss anything again.
This podcast is generated using artificial intelligence. Infectious disease scientists review the scripts before production.
All content for PhageLine is the property of Planomicrobium massiliensis and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
PhageLine unpacks the science of bacteriophages, one paper at a time. From groundbreaking studies to surprising discoveries, we translate complex research into engaging conversations. Whether you are steeped in microbiology or just discovering the fascinating world of phages, PhageLine delivers a unique perspective on the science behind these bacterial predators.
PhageLine is on BlueSky (@phageline.bsky.social). Follow us never to miss anything again.
This podcast is generated using artificial intelligence. Infectious disease scientists review the scripts before production.
PhageLine #8: Synergy of Mucoactive Drugs and Phages
PhageLine
15 minutes
4 days ago
PhageLine #8: Synergy of Mucoactive Drugs and Phages
PhageLine
PhageLine unpacks the science of bacteriophages, one paper at a time. From groundbreaking studies to surprising discoveries, we translate complex research into engaging conversations. Whether you are steeped in microbiology or just discovering the fascinating world of phages, PhageLine delivers a unique perspective on the science behind these bacterial predators.
PhageLine is on BlueSky (@phageline.bsky.social). Follow us never to miss anything again.
This podcast is generated using artificial intelligence. Infectious disease scientists review the scripts before production.